Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?
Kovács
Gábor T
GT
Haemato-oncology Division, 2nd Department of Pediatrics, Semmelweis University, Tuzolto 7-9., 1094, Budapest, Hungary. kovi@gyer2.sote.hu
Erlaky
Hajna
H
Tóth
Kornélia
K
Horváth
Erzsébet
E
Szabolcs
Judit
J
Csóka
Monika
M
Jókúti
László
L
Erdélyi
Dániel
D
Müller
Judit
J
D000208:Acute Disease; D018943:Anthracyclines / Q000009:adverse effects* / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced* / Q000517:prevention & control; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008297:Male; D011929:Razoxane / Q000627:therapeutic use; D012307:Risk Factors
D018943:Anthracyclines; D002317:Cardiovascular Agents; D011929:Razoxane